Key facts
- This page summarizes Brian L. Koopman's Form 4 filing for UTAH MEDICAL PRODUCTS INC (UTMD).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 25 Nov 2025, 18:25.
Brian L. Koopman - 31 Oct 2025 Form 4 Insider Report for UTAH MEDICAL PRODUCTS INC (UTMD)
- Reporting relationship
- Principal Financial Officer
- Issuer ticker
- UTMD
- Reported as of
- 31 Oct 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Nov 2025, 18:25:16 UTC
- Prior SEC filing
- 05 Sep 2025
- Next SEC filing
- 29 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian L. Koopman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brian L. Koopman filed Form 4 for UTAH MEDICAL PRODUCTS INC (UTMD) on 25 Nov 2025.
Change
- Previous filing in this sequence was filed on 05 Sep 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001733614
Primary reporting owner
Koopman Brian
- Relationship
- Principal Financial Officer
- Address
- 108 E 1700 S, BOUNTIFUL
- Signature
- /s/ Brian L. Koopman
- Signature date
- 25 Nov 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
UTMD
transaction
Derivative
Employee Stock Option - Right to Buy
Award
- Transaction value
- $0
- Shares
- +500
- Change %
- +9.8%
- Price
- $0.000000
- Shares after
- 5,600
- Date
- 31 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500
- Exercise price
- $58.10
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Option will vest 25% on 1/1/27, and an additional 6.25% on 4/1/27 and the first day of each calendary quarter thereafter. Fully exercisable on 1/1/30.